AHR and obesity disorder: Our data suggest that, at least in the mouse with obesity-associated AHR, the heightened CCK/CCKAR signaling in the lung appears to lead to increased ASM contraction that is independent of airway inflammation as CCKAR antagonists did not alter markers of inflammation.